AMBER HAUSKINS: Open Payments
NPI 1053059923 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,346 in 115 payments from 20 companies in 2025. Trend: 2023 $1,715 · 2024 $1,997 · 2025 $2,346
Food & beverage: $2,248Education: $98
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $383 |
| GlaxoSmithKline, LLC. | 25 | $335 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $204 |
| Viatris Specialty LLC | 11 | $200 |
| GENZYME CORPORATION | 13 | $188 |
| Verona Pharma, Inc. | 6 | $180 |
| Actelion Pharmaceuticals US, Inc. | 7 | $142 |
| Regeneron Healthcare Solutions, Inc. | 7 | $135 |
| Merck Sharp & Dohme LLC | 6 | $129 |
| SANOFI-AVENTIS U.S. LLC | 1 | $98 |
Products named: DUPIXENT, BREZTRI, NUCALA, GLASSIA, YUPELRI, Ohtuvayre, OPSUMIT, AIRSUPRA.
Industry payments across AZ — which companies pay providers there.
